Skip to main content
Equibles

HEALTHX · Health X Platform Limited · Financials

Use HEALTHX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HEALTHX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
272.30 INR -1.95 (-0.71%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 53 Avg daily vol (3M) 480

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
13.19B +18.8%
FY2026 Revenue FY2020–FY2026
Net Income
11.76M +101.3%
FY2026 Net Income FY2020–FY2026
Operating Cash Flow
-738.3M -326.5%
FY2026 Operating Cash Flow FY2023–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2021 FY2020
INR 14.68B 13.19B 11.11B 13.76B 10.4B 5.48B 3.85B
INR 73.23M 66.03M 58.29M 91.38M 81.98M 44.73M 49.02M
INR 12.9M 7.82M 2.17M 10.09M 8.68M 10.49M 7.02M
INR -305.69M -23.58M — — — -163.67M -575.69M
INR -45.17M -9.1M -701.22M -363.51M -227.82M 7.25M -54.37M
INR -201.95M 11.76M -911.67M 88.83M -722.11M -104.01M -387.94M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.